Arcinova, a Quotient Sciences company and UK-based contract research development and manufacturing organisation (CRDMO), has ...

SOM Biotech has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medical Products for SOM3355, a candidate therapy for Huntington’s disease (HD). The molecule ...

Eisai has presented new clinical data for its investigational orexin 2 receptor agonist E2086 at the World Sleep 2025 ...

Bluejay Therapeutics has enrolled the first patient in AZURE-2, a global phase 3 clinical trial evaluating brelovitug ...

Merck has announced positive phase 3 results for Capvaxive, its 21-valent pneumococcal conjugate vaccine, in children and ...

lzeCure Pharma has presented new clinical data on its lead pain candidate ACD440 at the NeuPSIG 2025 international pain ...

Lundbeck has presented new clinical data on eptinezumab at the 2025 International Headache Congress in São Paulo, ...

Thierry Van Nieuwenhove, CEO at Quotient Sciences, said: “This is a pivotal moment for RNA drug development. The combined ...

Dr Deepika Jalota, Chief Development Officer, said: “These phase 2 PYNNACLE interim trial data illustrate that rezatapopt, a ...

Abcuro Inc, a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer ...

The 2025 Medical Scientific Excellence Awards and the Nursing Industry Excellence Awards, at The Royal Horseguards Hotel in ...

Daiichi Sankyo & AstraZeneca. Breast Cancer Awareness Survey in Europe conducted in October 2024. Available at: ...